SwRI gets $9.9M to develop battlefield antidote
San Antonio-based Southwest Research Institute received funding from the Medical CBRN Defense Consortium to develop a nerve agent antidote for use on the battlefield or to protect the public.
San Antonio-based Southwest Research Institute received funding from the Medical CBRN Defense Consortium to develop a nerve agent antidote for use on the battlefield or to protect the public.
Medical CBRN Defense Consortium (MCDC) has released a Request for Information (RFI) seeking solutions to combat the novel Coronavirus (2019-nCoV) pandemic.
To help figure it out, last year the Pentagon began funding a research group called the National Spectrum Consortium. To learn what it’s been up to, Federal Drive with Tom Temin spoke with the consortium’s chairman, Sal D’Itri.